Access the full text.
Sign up today, get DeepDyve free for 14 days.
(2008)
Small cell and other neuroendocrine tumors of the lung
F. Tanaka, K. Yoneda, N. Kondo, M. Hashimoto, T. Takuwa, S. Matsumoto, Y. Okumura, S. Rahman, N. Tsubota, T. Tsujimura, K. Kuribayashi, K. Fukuoka, T. Nakano, S. Hasegawa (2009)
Circulating Tumor Cell as a Diagnostic Marker in Primary Lung CancerClinical Cancer Research, 15
J. Bono, H. Scher, R. Montgomery, C. Parker, M. Miller, H. Tissing, G. Doyle, L. Terstappen, K. Pienta, D. Raghavan (2008)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate CancerClinical Cancer Research, 14
B. Kularatne, Paul Lorigan, S. Browne, S. Suvarna, M. Smith, John Lawry (2002)
Monitoring tumour cells in the peripheral blood of small cell lung cancer patients.Cytometry, 50 3
A. Inoue, S. Sugawara, K. Yamazaki, M. Maemondo, Toshiro Suzuki, K. Gomi, S. Takanashi, C. Inoue, M. Inage, H. Yokouchi, H. Watanabe, T. Tsukamoto, Y. Saijo, O. Ishimoto, F. Hommura, T. Nukiwa (2008)
Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 33
R. Loberg, Y. Fridman, Brian Pienta, E. Keller, L. McCauley, R. Taichman, K. Pienta (2004)
Detection and isolation of circulating tumor cells in urologic cancers: a review.Neoplasia, 6 4
S. Maheswaran, L. Sequist, S. Nagrath, L. Ulkus, Brian Brannigan, Chey Collura, Elizabeth Inserra, S. Diederichs, A. Iafrate, D. Bell, S. Digumarthy, A. Muzikansky, A. Muzikansky, D. Irimia, J. Settleman, R. Tompkins, Ronald Tompkins, T. Lynch, M. Toner, M. Toner, D. Haber, D. Haber (2008)
Detection of mutations in EGFR in circulating lung-cancer cells.The New England journal of medicine, 359 4
M. Wicha, D. Hayes (2011)
Circulating tumor cells: not all detected cells are bad and not all bad cells are detected.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 12
M. Krebs, R. Sloane, L. Priest, L. Lancashire, Jian-mei Hou, A. Greystoke, T. Ward, R. Ferraldeschi, A. Hughes, G. Clack, M. Ranson, C. Dive, F. Blackhall (2011)
Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 12
Ewa Wójcik, J. Kulpa, B. Sas-Korczyńska, S. Korzeniowski, J. Jakubowicz (2008)
ProGRP and NSE in therapy monitoring in patients with small cell lung cancer.Anticancer research, 28 5B
B. Nisman, H. Biran, N. Ramu, N. Heching, V. Barak, T. Peretz (2009)
The diagnostic and prognostic value of ProGRP in lung cancer.Anticancer research, 29 11
M. Cristofanilli, D. Hayes, G. Budd, M. Ellis, A. Stopeck, J. Reuben, G. Doyle, J. Matera, W. Allard, M. Miller, H. Fritsche, G. Hortobagyi, L. Terstappen (2005)
Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 7
T. Shibayama, H. Ueoka, K. Nishii, K. Kiura, M. Tabata, K. Miyatake, T. Kitajima, M. Harada (2001)
Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC).Lung cancer, 32 1
E. Eisenhauer, P. Therasse, J. Bogaerts, L. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, Lawrence Rubinstein, L. Shankar, L. Dodd, Robert Kaplan, D. Lacombe, J. Verweij (2009)
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).European journal of cancer, 45 2
Chi Wu, H. Hao, Long-yun Li, Xiaoyun Zhou, Zijian Guo, Li Zhang, Xiaotong Zhang, W. Zhong, Huiqin Guo, R. Bremner, Ping Lin (2009)
Preliminary Investigation of the Clinical Significance of Detecting Circulating Tumor Cells Enriched from Lung Cancer PatientsJournal of Thoracic Oncology, 4
B. Molnár, F. Sipos, O. Galamb, Z. Tulassay (2004)
Molecular Detection of Circulating Cancer CellsDigestive Diseases, 21
P. Fetsch, K. Cowan, D. Weng, Allison Freifield, A. Filie, A. Abati (2000)
Detection of circulating tumor cells and micrometastases in Stage II, III, and IV breast cancer patients utilizing cytology and immunocytochemistryDiagnostic Cytopathology, 22
(2002)
A sample preparation and analysis system for identification of circulating tumor cells
Minetta Liu, P. Shields, R. Warren, P. Cohen, M. Wilkinson, Y. Ottaviano, Suman Rao, J. Eng-Wong, F. Seillier-Moiseiwitsch, A. Noone, C. Isaacs (2009)
Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 31
M. Puglisi, S. Dolly, Ana Faria, J. Myerson, S. Popat, Mary O'Brien (2010)
Treatment options for small cell lung cancer – do we have more choice?British Journal of Cancer, 102
Henry Lin, M. Balić, Si-Yang Zheng, R. Datar, R. Cote (2011)
Disseminated and circulating tumor cells: Role in effective cancer management.Critical reviews in oncology/hematology, 77 1
H. Scher, X. Jia, J. Bono, M. Fleisher, K. Pienta, D. Raghavan, G. Heller (2009)
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data.The Lancet. Oncology, 10 3
J. Pawel, J. Schiller, F. Shepherd, S. Fields, J. Kleisbauer, N. Chrysson, D. Stewart, P. Clark, M. Palmer, A. Depierre, J. Carmichael, J. Krebs, G. Ross, S. Lane, R. Gralla (1999)
Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 17 2
T. Sher, G. Dy, A. Adjei (2008)
Small cell lung cancer.Mayo Clinic proceedings, 83 3
Jackman (2005)
Small-cell lung cancerLancet, 366
S. Riethdorf, H. Fritsche, V. Müller, T. Rau, C. Schindlbeck, B. Rack, W. Janni, C. Coith, K. Beck, F. Jänicke, S. Jackson, T. Gornet, M. Cristofanilli, K. Pantel (2007)
Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch SystemClinical Cancer Research, 13
(2009)
Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy
K. Albain, J. Crowley, M. LeBlanc, R. Livingston (1991)
Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 9 9
M. Ignatiadis, F. Rothé, C. Chaboteaux, V. Durbecq, G. Rouas, C. Criscitiello, Jessica Metallo, N. Kheddoumi, S. Singhal, S. Michiels, I. Veys, J. Rossari, D. Larsimont, B. Carly, M. Pestrin, S. Bessi, F. Buxant, F. Liebens, M. Piccart, C. Sotiriou (2011)
HER2-Positive Circulating Tumor Cells in Breast CancerPLoS ONE, 6
Steven Cohen, C. Punt, N. Iannotti, B. Saidman, K. Sabbath, N. Gabrail, J. Picus, M. Morse, E. Mitchell, M. Miller, G. Doyle, H. Tissing, L. Terstappen, Neal Meropol (2009)
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer.Annals of oncology : official journal of the European Society for Medical Oncology, 20 7
D. Roukos, S. Murray, E. Briasoulis (2007)
Molecular genetic tools shape a roadmap towards a more accurate prognostic prediction and personalized management of cancerCancer Biology & Therapy, 6
M. Leversha, Jialian Han, Zahra Asgari, D. Danila, O. Lin, Rita Gonzalez-Espinoza, A. Anand, H. Lilja, G. Heller, M. Fleisher, H. Scher (2009)
Fluorescence In situ Hybridization Analysis of Circulating Tumor Cells in Metastatic Prostate CancerClinical Cancer Research, 15
Steven Cohen, C. Punt, N. Iannotti, B. Saidman, K. Sabbath, N. Gabrail, J. Picus, M. Morse, E. Mitchell, M. Miller, G. Doyle, H. Tissing, L. Terstappen, Neal Meropol (2008)
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 19
W. Allard, J. Matera, M. Miller, M. Repollet, M. Connelly, C. Rao, A. Tibbe, J. Uhr, L. Terstappen (2004)
Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant DiseasesClinical Cancer Research, 10
M. Cristofanilli, G. Budd, M. Ellis, A. Stopeck, J. Matera, M. Miller, J. Reuben, G. Doyle, W. Allard, L. Terstappen, D. Hayes (2004)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer.The New England journal of medicine, 351 8
T. Fehm, V. Müller, B. Aktas, W. Janni, A. Schneeweiss, E. Stickeler, C. Lattrich, Christian Löhberg, E. Solomayer, B. Rack, S. Riethdorf, C. Klein, C. Schindlbeck, K. Brocker, S. Kasimir-Bauer, D. Wallwiener, K. Pantel (2010)
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trialBreast Cancer Research and Treatment, 124
S. Riethdorf, V. Müller, Liling Zhang, T. Rau, S. Loibl, M. Komor, M. Roller, J. Huober, T. Fehm, I. Schrader, J. Hilfrich, F. Holms, H. Tesch, H. Eidtmann, M. Untch, G. Minckwitz, K. Pantel (2010)
Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro TrialClinical Cancer Research, 16
S. Nagrath, L. Sequist, S. Maheswaran, D. Bell, D. Irimia, L. Ulkus, Matthew Smith, E. Kwak, S. Digumarthy, A. Muzikansky, P. Ryan, U. Balis, R. Tompkins, D. Haber, M. Toner (2007)
Isolation of rare circulating tumour cells in cancer patients by microchip technologyNature, 450
Yuqiu Jiang, J. Palma, D. Agus, Yixin Wang, M. Gross (2010)
Detection of androgen receptor mutations in circulating tumor cells in castration-resistant prostate cancer.Clinical chemistry, 56 9
ORIGINAL ARTICLE Prognostic Impact of Circulating Tumor Cells in Patients with Small Cell Lung Cancer Tateaki Naito, MD, PhD,* Fumihiro Tanaka, MD, PhD,† Akira Ono, MD,* Kazue Yoneda, BS,‡ Toshiaki Takahashi, MD, PhD,* Haruyasu Murakami, MD, PhD,* Yukiko Nakamura, MD,* Asuka Tsuya, MD, PhD,* Hirotsugu Kenmotsu, MD,* Takehito Shukuya, MD,* Kyoichi Kaira, MD, PhD,§ Yasuhiro Koh, MD, Masahiro Endo, MD, PhD,¶ Seiki Hasegawa, MD, PhD,‡ and Nobuyuki Yamamoto, MD, PhD* Key Words: Circulating tumor cells, Small cell lung cancer, Background: Enumeration of circulating tumor cells (CTCs) may be Prognosis. valuable for prognostic assessment in lung cancer patients. In this study, we report the clinical significance of CTCs in small cell lung cancer (J Thorac Oncol. 2012;7: 512–519) (SCLC). Methods: In total, 51 consecutive patients newly diagnosed as having SCLC and starting chemotherapy or chemoradiotherapy mall cell lung cancer (SCLC) accounts for 15% of all lung were prospectively enrolled. Blood samples were drawn at the Scancer diagnoses and is characterized by aggressive tumor baseline, after chemotherapy, and at relapse. CTCs were isolated growth, often presenting with metastases in the regional using the CellSearch System (Veridex LLC). Thresholds of 1 to 100 lymph nodes and distant organs. Because SCLC is highly
Journal of Thoracic Oncology – Wolters Kluwer Health
Published: Mar 1, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.